Larvol Delta - BioSig-subsidiary-NeuroClear-acquires-license-for-a-broadspectrum-antiviral-agent-that-may-treat-COVID19-Laboratory-results-demonstrate-high-level-of-activity-against-COVID19-in-cell-culture

Vicromax - BioSig Tech

http://www.globenewswire.com/news-release/2020/03/25/2006132/0/en/BioSig-subsidiary-NeuroClear-acquires-license-for-a-broad-spectrum-anti-viral-agent-that-may-treat-COVID-19-Laboratory-results-demonstrate-high-level-of-activity-against-COVID-19-i.html

Mar 31, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next